SEEDSUPPLY

MENU

Research

Scientific Research at SEEDSUPPLY

SEEDSUPPLY advances early-stage drug discovery through experimental binding technologies, large-scale compound screening, and systematic studies of challenging drug targets.

Our research focuses on generating experimental binding data, discovering new chemical starting points, and evaluating the applicability of AI-based approaches to drug discovery.

Publications

Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery

SLAS Discovery (2026)

Binder2030 provides experimentally validated small-molecule binders for approximately 400 membrane protein targets, including GPCRs, SLC transporters, and ion channels.

Read the publication

Scientific Webinars

Our scientific webinars explore the challenges and opportunities of experimental drug discovery, including AI-based virtual screening, small-molecule hit discovery, and target identification.

New webinars will be announced following the publication of our latest research.